Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback